4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Adocia SA (ADOC) operates in the Biotechnology industry and is headquartered in Lyon, France with about 73 employees. Its market capitalization is roughly €83 million. In the fiscal year ended 2025-12-31, ADOC reported €2M in revenue and (€17M) in net income.
Adocia SA, a clinical-stage biotechnology company, researches and develops therapeutic solutions for diabetes and obesity. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | €2M | €9M | €2M | €11M | — |
| Gross Profit | €1M | €8M | €1M | €10M | — |
| Operating Income (EBIT) | (€16M) | (€7M) | (€14M) | (€2M) | — |
| Net Income | (€17M) | (€9M) | (€21M) | (€7M) | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | €28M | €27M | €25M | €31M | — |
| Total Liabilities | €27M | €30M | €32M | €44M | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ADOC viewer.
About TickerBase · Data methodology & sources · Privacy · Terms